Loading...
Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Table of Content

    Volume 28 Issue 4
    26 April 2023
    Effect of Zhiwei Fuwei Pills on autophagy in gastric antrum tissue of rats with precancerous lesions of gastric cancer based on mTOR/Beclin1/LC3 signaling axis
    FENG Zhuangzhuang, SONG Ruiping, DOU Pengcheng, CHEN Xinyi, ZUO Jiaojiao, SHU Jin
    2023, 28(4):  361-370.  doi:10.12092/j.issn.1009-2501.2023.04.001
    Asbtract ( 156 )   PDF (4000KB) ( 150 )  
    Related Articles | Metrics
    AIM: To investigate the effect of Zhiwei Fuwei Pills (ZWFW) on the expression of mammali- an target of rapamycin(mTOR)/autophagy key molecule yeast Atg6 homologue (Beclin1)/microtubule-associated protein 1 light chain 3 (LC3) signaling axis key molecules in gastric antrum tissue of rats with precancerous gastric lesions (PLGC). METHODS: SPF SD rats were randomly divided into normal group, model group, folic acid group, ZWFW low-dose, medium-dose, high-dose group. In addition to the normal group, the model group, folic acid group, ZWFW low-dose, medium-dose and high-dose groups, were used to establish the PLGC rat model by five factors compound modeling methods: N-methyl-N'-nitro-n-nitroguanidine (MNNG) combined with hunger and satiation, ethanol intragastric administration, free drinking of ammonia and ranitidine feed. The rats were treated with normal saline, folic acid tablet aqueous solution (0.002 g/kg),ZWFW low-dose, medium-dose, high-dose aqueous solution (0.42, 0.84, 1.67 g/kg) for 4 weeks, and the stomach was removed by laparotomy. Hematoxylineosin (HE) staining was used to observe the histo-pathological changes in the antrum of rats, and real- time polymerase chain reaction (real-time PCR), Western blot(WB) and immunohistochemistry (IHC) were used to detect the expression of mammalian target of rapamycin mTOR, yeast Atg6 homologue 1 (Beclin1), microtubule-associated protein 1 light chain 3β(LC3B) mRNA and protein in the antrum of rats. RESULTS: Compared with the normal group, the Gastric antrum tissue of the  model  group was distended, thinner gastric wall, palegastric mucosa, atrophic and flat folds, disordered course and nodules and vegetations were  visible. HE staining showed that compared with the normal group, the gastric mucosal glands in the model group were crowded and disordered, and the cell morphology was different, including a large number of goblet cells, basophilic cytoplasm, large, hyper-chromatic and irregular nuclei, and mucosal muscle infiltration and destruction. Compared with the model group, treated by ZWFW can significantly improve the pathological manifestations of gastric mucosal gland structure disorder and cell atypia. Compared with the normal group, mTOR mRNA and protein expression were significantly increased (P<0.05) and Beclin1 and LC3B mRNA and protein expression were significantly decreased (P<0.05) in the antral tissue of rats in the model group; compared with the model group, mTOR mRNA and pro- tein expression were decreased (P<0.05) in the medium and high dose groups of ZWFW, Beclin1 and LC3B protein expression in the antral tissue of rats in the low dose group of ZWFW and Beclin1 and LC3B mRNA and protein expression were increased (P<0.05) in the medium and high dose groups. CONCLUSION: Zhiwei Fuwei Pills can significantly improve the abnormal histopathological findings of gastric mucosa in PLGC model rats, and the mechanism may be related to the down-regulation of mTOR expression, up-regulation of Beclin1  and LC3B expression and then promoting autophagy.
    Gene expression in rhesus macaques prefrontal cortex after multiple sevoflurane exposures
    SHI Lingling, ZHANG Lei
    2023, 28(4):  371-376.  doi:10.12092/j.issn.1009-2501.2023.04.002
    Asbtract ( 136 )   PDF (1930KB) ( 76 )  
    Related Articles | Metrics
    AIM: To analyze differentially expressed genes after multiple sevoflurane anesthesia in rhesus macaques was studied. METHODS: Rhesus macaques received three anesthetic exposures to sevoflurane on postnatal day (P) 7 and then on P21 and P35. RNA sequencing analysis was used in the studies. RESULTS: Transcriptomic analysis of differentially expressed genes (DEGs) revealed that up-regulated genes were mainly enriched in the regulation of positive regulation of gastrulation and odontogenesis, while down-regulated genes were primarily enriched in the regulation of transcriptional activator activity, RNA poly-merase II transcription regulatory region sequence-specific binding, and MAPK signaling pathway. CONCLUSION: Differentially expressed genes (DEGs) were analyzed in the prefrontal cortex of rhesus macaques after multiple sevoflurane exposures by RNA sequencing to screen essential genes for subsequent studies on neurotoxicity induced by sevoflurane, providing a solid basis for the study of the mechanism of general anesthesia.
    Effects of Xiaokeshu recipe on levels of serum inflammatory factors  in type2 diabetic rats and its mechanism
    HOU Ruiying, GUO Lige, JIAO Weijie, DU Lei, WU Guiyue, ZHAO Xu
    2023, 28(4):  377-382.  doi:10.12092/j.issn.1009-2501.2023.04.003
    Asbtract ( 114 )   PDF (977KB) ( 93 )  
    Related Articles | Metrics
    AIM: To explore the possible mechanism of Xiaokeshu recipe in the treatment of type 2 diabetes mellitus (T2DM) by observing the effects of Xiaokeshu Recipe on serum inflammatory factors. METHODS: Male SPF-grade SD rats were fed with high-fat and high-sugar fodder combined with intraperitoneal injection of streptozotocin (STZ) to prepare the model of T2DM. The model rats were randomly divided into a model group, a metformin group, low and high-dose Xiaokeshu recipe groups, and a normal group was set up. After successful modeling, the metformin group and the Xiaokeshu recipe groups were treated with metformin and Xiaokeshu recipe by gavage respectively, normal saline was given by gavage in the normal group and the model group. The general living status of rats before and after treatment was observed. After 4 weeks of drug intervention, serum samples and ileum tissue of rats were collected for biochemical and Western blot. RESULTS: As compaed with the model group,the polydipsia and polyuria in the low and high-dose Xiaokeshu recipe and the metformin groups could be improved. As compaed with the model group, the levels of fasting blood glucose (FBG), fasting insulin (FINS) and interleukin-1β (IL-1β) of rats in the low-dose Xiaokeshu recipe group were decreased, but the differences were statisti- cally insignificant (P>0.05), the levels of FBG, FINS and IL-1β of rats in the high-dose Xiaokeshu recipe and the metformin groups were significantly decreased as compared with the the model group (P<0.05 or P<0.01). As compaed with the model group, the levels of Lipopolysaccharide (LPS), interleukin-6 (IL-6), and tumor necrosis factor-α(TNF-α) in the high-dose Xiaokeshu recipe and the metfor- min groups were decreased (P<0.05 or P<0.01). As compared with the model group, the expressions of toll-like receptor 4 (TLR4) and nuclear transcription factor (NF-κB) protein in ileal tissue were down-regulated in the low and high-dose Xiaokeshu Recipe and the metformin groups (P<0.05 or P<0.01). CONCLUSION: Xiaokeshu recipe may reduce the level of serum LPS, inhibit the TLR4 / NF-κB signaling pathway, and reduce the release of inflammatory factors, thus improving insulin resistance and reducing the blood sugar of the body.
    Effectss of hyperoside on traumatic brain injury rats by regulating RhoA/ROCK signaling pathway
    XU Wei, CHEN Feng, YE Zhijun
    2023, 28(4):  383-390.  doi:10.12092/j.issn.1009-2501.2023.04.004
    Asbtract ( 112 )   PDF (954KB) ( 115 )  
    Related Articles | Metrics
    AIM: To investigate the effects of hyperoside on traumatic brain injury (TBI) rats by regulating the Ras homolog gene family, member A (RhoA)/Rho-associated coiled coil-forming kinase (ROCK) signal pathway. METHODS: The TBI rat model was established by modified Feeney free fall hit method, and was randomly divided into model group, low-dose hyperoside (60 mg/kg) group, high-dose hyperoside (120 mg/kg) group, high-dose hyperoside (120 mg/kg)+ no load group, and high-dose hyperoside (120 mg/kg) + RhoA overexpression group, with 10 rats in each group, another 10 healthy rats were set as sham operation group, after hyperoside and plasmid were grouped, the nerve injury was detected by modified neurological deficit score (mNSS) and dark avoidance test; Evans blue (EB) quantitative method was used to detect the permeability of blood brain barrier in rats; ultrastructural damage of blood-brain barrier was observed by transmission electron microscopy; the levels of tumor necrosis factor-α(TNF-α), interleukin-8 (IL-8), superoxide dismutase (SOD) and malondialdehyde (MDA) in serum and brain tissue  of rats were measured with the kit; and the expression of RhoA/ROCK pathway related proteins in rat brain was detected by Western blot. RESULTS: Compared with the sham operation group, the blood brain barrier structure of the model group rats was damaged, the step-through latency and SOD level decreased obviously (P<0.05), the mNSS score, the number of mistakes, the content of EB in brain tissue, the levels of TNF-α,IL-8, MDA in serum and brain tissue, and the expression of RhoA, ROCK1, ROCK2 proteins in brain tissue increased obviously (P<0.05). Compared with the model group, the damage of blood brain barrier structure of rats in the low-dose hyperoside group and the high-dose hyperoside group was alleviated, the step-through latency and SOD level increased (P<0.05), the mNSS score,the number of mistakes, the content of EB in brain tissue, the levels of TNF-α, IL-8, MDA in serum and brain tissue, and the expression of RhoA, ROCK1, ROCK2 proteins in brain tissue all decreased (P<0.05); high-dose hyperoside group has stronger effect. Overexpression of RhoA can reverse the effects of high-dose hyperoside on various indexes of TBI rats; there was no obvious change in all indexes in high-dose hyperoside+empty load group (P>0.05). CONCLUSION: Hyperoside can inhibit neuroinflammation and oxidative stress in TBI rats by down-regulating RhoA/ROCK signal pathway, thereby reducing the damage of blood brain barrier and repairing its neural function.
    Implication of XPC rs2228001 polymorphism on the prognosis of patients with colorectal cancer who were treated with capecitabine-based adjuvant chemotherapy
    SHI Dawei, ZHENG Xiaoyong, JIN Xiaodan, ZHAO Xiaoman, CHEN Jie, DU Xingjun
    2023, 28(4):  391-399.  doi:10.12092/j.issn.1009-2501.2023.04.005
    Asbtract ( 124 )   PDF (1620KB) ( 96 )  
    Related Articles | Metrics
    AIM: Nucleotide excision repair was a complex biochemical process that involved in the repair of many kinds of DNA damage. Previous study suggested that xeroderma pigmentosum group C (XPC) gene played an important role in the process of DNA damage repair. This study aimed to explore the influence of XPC gene  polymorphism on the prognosis of patients with colorectal cancer (CRC) who were treated with capecitabine-related adjuvant chemotherapy. METHODS: A total of 158 patients with CRC who received surgical resection and capecitabine-based adjuvant chemotherapy were included in this study consecutively. Baseline clinical characteristics of patients were collected and analyzed. Additionally, peripheral blood specimens of the patients were collected for polymorphism analysis of XPC gene and mRNA expression of XPC, respectively. The association analysis between XPC polymorphism and prognosis and mRNA expression was performed. Cox regression analysis was used for multivariate adjustment. RESULTS: Prognostic data in the 158 patients with CRC who received capecitabine-based adjuvant chemotherapy was collected retrospectively. The median follow-up duration of the patients was 5.0 years (range: 0.25-7.5 years). The median DFS and OS of the 158 patients with CRC was 4.5 years and 5.7 years, respectively. XPC polymorphism analysis suggested that rs2228001 was of clinical signifi- cance. The prevalence of rs2228001 polymorphism among CRC patients was: TT genotype 86 cases (54.4%), TG genotype 60 cases (38.0%) and GG genotype 12 cases (7.6%), resulting in a minor allele frequency of 0.27, which was in accordance with Hardy-Weinberg equilibrium (P=0.733). TG and GG genotypes were merged in the subsequent analysis. The prognostic results exhibited that the median DFS of patients with TT genotype and TG/GG genotype was 4.5 and 5.7 years, respectively (?2= 7.072, P=0.008). Furthermore, the median OS of the two genotypes were 5.0 and 5.9 years (?2= 5.416, P=0.020). Additionally, analysis of XPC gene mRNA expression in 65 specimens suggested that the mRNA expression of XPC in PBMC of the patients with TG/GG genotypes were significantly higher than that of the patients with TT genotype (t=6.478, P<0.001). CCONCLUSION: Polymorphism of rs2228001 in XPC gene was associated with prognosis of patients with CRC who received capecitabine-based adjuvant chemotherapy. And the conclusion should be confirmed in prospective clinical trials subsequently.
    Correlation between progesterone receptor G1978T polymorphism and endometrial cancer
    ZHOU Jing, ZHOU Chen, LIAO Ke, QIU Ailin, DONG Weilei, GUO Zifen
    2023, 28(4):  400-406.  doi:10.12092/j.issn.1009-2501.2023.04.006
    Asbtract ( 110 )   PDF (870KB) ( 60 )  
    Related Articles | Metrics
    AIM: To explore the relationship between progesterone receptor (PGR) gene G1978T polymorphism and endometrial carcinoma. METHODS: After searching PubMed, EMBASE, Wan-fang and CNKI databases for literatures on PGR G1978T genotyping of endometrial cancer patients, the da- ta were extracted and odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using STATA15. The whole blood samples of endometrial carcinoma cases (EC group) and normal women (control group) were collected. Allelic-specific primers matching G1978T wild type G allele and mutant type T allele were designed with 3'terminal phos-phorothioate modification, and the two-directional primer extension was performed using Exo+polymerase to genotype PGR gene G1978T polymorphism and Sanger sequencing was used to  verify the genotype. RESULTS: PGR gene G1978T mutation was marginally associated with endometrial carcinoma risk (ORper allele =1.10,95%CI=0.98-1.24, P=0.072). At the same time, only 1 normal blood samples were found with PGR gene G1978T mutation, and the differences in genotypes and allele frequency between the case group and the control group were not statistically significant(P>0.05).CONCLUSION: The G1978T polymorphism of the PGR gene maybe not be associated with the risk of endometrial carcinoma.
    Clinical study of TBX21 and ADCY9 polymorphisms in the develop- ment of childhood asthma
    ZHANG Zhiying, JIN Xiuhong, ZHANG Xiaoning, ZHANG Xiangfeng, LUO Qinglin, ZHANG Songlin
    2023, 28(4):  407-412.  doi:10.12092/j.issn.1009-2501.2023.04.007
    Asbtract ( 122 )   PDF (707KB) ( 80 )  
    Related Articles | Metrics
    AIM: To investigate the clinical role of T-cell transcription factor (TBX21) and adenylate cyclase 9 antibody (ADCY9) gene polymorphisms in the development of childhood asthma. METHODS: Two hundred Han Chinese wheezing children aged 5 years and younger in Henan region from July  2016 to January 2017 were selected as the study group, and another 100 Han Chinese healthy children aged 5 years and younger in the same period were selected as the control group. Oral mucosal exfoliated cells were collected from both groups, and the genotypes of TBX21 gene rs2240017 polymorphic locus and ADCY9 gene rs2230739 polymorphic locus were detected by real-time fluorescence quantitative polymerase chain reaction (PCR) tech- nique, and the risk level of asthma was assessed based on the test results. The children in the low-risk and high-risk groups were compared in terms of serum immunoglobulin E (IgE) levels, API positivity rate and allergic disease incidence, and the correlation between the risk level of asthma-related genetic polymorphisms and serum IgE levels, API and allergic disease incidence was analyzed. All children were followed up until 6 years of age to confirm the diagnosis of asthma, and the incidence of asthma was compared between the low-risk and high-risk groups. Children with asthma were treat- ed with inhaled glucocorticoids and leukotriene receptor antagonists for 3 months, and the control of asthma and the impairment of lung function were compared between the low-risk and high-risk groups. RESULTS: The genotype detection results of rs2240017 polymorphic locus of TBX21 gene and rs2230739 polymorphic locus of ADCY9 gene in the study group compared with those in the control group were statistically significant (P<0.001). The percentages of CC, CT, and TT genotypes of rs2240017 polymorphic locus of TBX21 gene were 19.50%, 56.00%, and 24.50%, respectively, and the percentages of CC, CG, and GG genotypes of rs2230739 polymorphic locus of ADCY9 gene were 86.00%, 10.00%, and 4.00%, respectively, in 200 children with wheezing; serum IgE level, API positiv- ity rate and allergic disease incidence were higher in the high-risk group than in the low-risk group (P< 0.001, <0.001, 0.021, respectively). The degree of risk of asthma-related gene polymorphisms in children with wheezing was positively correlated with serum IgE levels, API positivity, and the incidence of allergic diseases (P<0.001); the incidence of asthma (81.48%) and impaired lung function (74.07%) were higher in the high-risk group than in the low-risk group (4.90%, 3.50%) (P<0.001). There was no statistically significant difference between the asthma control rate of children with asthma in the high-risk group (79.55%) compared with the asthma control rate of children with asthma in the low-risk group (100.00%) (P=0.433). CONCLUSION: Gene polymorphisms at rs2240017 locus of TBX21 gene and rs2230739 locus of ADCY9 gene are closely associated with asthma development and impaired lung function in children with wheezing.
    Changes of anesthetic drug concentration in plasma during isolation of autologous blood with acute isovolumic hemodilution and its influence on anesthetic effect after reinfusion
    LIU Tong, XU Jiaming, WANG Jinhuo, YIN Lei, CHEN Yongquan, GUO Jianrong
    2023, 28(4):  413-418.  doi:10.12092/j.issn.1009-2501.2023.04.008
    Asbtract ( 115 )   PDF (1320KB) ( 77 )  
    Related Articles | Metrics
    AIM: To investigate the changes of anesthetic drug concentration in plasma during isolation of autologous blood with acute normovolemic hemodilution and its influence on the depth of anesthesia, muscle relaxant effect and blood drug concentration after reinfusion. METHODS: Forty patients of both sexes, aged 20-60 yr, American Society of Anesthesiologists physical status ⅠorⅡ, hemoglobin (Hb) >120 g/L, hematocrit (Hct) >35%,undergoing eletive multilevel spinal surgery were included, were divided into 2 groups (n=20 each) using a random number table. ANH group (group A): ANH was performed after stable induction of anesthesia, the target Hct value was 28%-30%, and autologous blood was reinfused after the main operation steps. Control group (group C): routine transfusion and infusion treatment. The bispectral index (BIS) and Train-of-Four stimulation (TOF) were observed and recorded at the stable induction of anesthesia (T1), 30 minutes of stable induction (T2), the end of operation (T3), 30 minutes after the end of the operation (T4), 1 hour after the end of the operation (T5) and 2 hours after the end of the operation (T6). The concentrations of propofol and cisatracurium besylate in plasma at T1-T6, stored blood at 1 h (TS1), 2 h(TS2), and before reinfusion (TS3) were detected by Liquid Chromatography- tandem Mass Spectrometry. The extubation time and recovery score at T4-6 hours were recorded. RE- SULTS: There was no significant difference in propofol between the two groups at each time point (P>0.05). The plasma concentration of cisatracurium besylate in group A was higher than that in group C at T3 (P<0.05). The concentration of two kinds of anesthetic drugs in blood samples decreased slightly with time,but there was no significant difference between groups (P>0.05). The BIS value at T4 and TOF value at T3 in group A were significantly lower than those in group C. The recovery score of group A was lower than that of group C at T4 (P<0.05). There was no significant difference in extubation time (P>0.05). CONCLUSION: The plasma concentrations of propofol and cisatracurium besylate were basically unchanged during the in vitro isolation of ANH autologous blood. The plasma concentrations of cisatracurium besylate were only temporarily affected after the main operation steps, but the postoperative muscle relaxation recovery and recovery quality were not significantly affected.
    Advances in clinical research on drug-induced acute interstitial nephritis
    ZHANG Mingkang, MA Yanrong, JIN Yongwen, ZHOU Yan, CUI Ruirui, WU Xin'an
    2023, 28(4):  419-428.  doi:10.12092/j.issn.1009-2501.2023.04.009
    Asbtract ( 140 )   PDF (1589KB) ( 140 )  
    Related Articles | Metrics
    The kidneys are one of the main excretory organs for drugs and when drugs are not excreted effectively, they can accumulate in the kid- neys or in the interstitial tubules, leading to drug-induced kidney injury. The tubulointerstitium accounts for 80% of the volume of the kidney and is the primary site of response to various types of renal injury. This article focuses on drug-induced acute interstitial nephritis, highlighting its clinical symptoms, listing common induction drugs, analysing pathological features, and explaining its pathogenesis from the perspective of immune response, with the aim of providing a basic and clinical evidence for subsequent studies.
    Research status of dialectical prevention and treatment of acute lung injury based on the theory of "Wei qi and Ying Xue"
    QI Xiaofeng, LUO Yali, XIAO Mengyong, ZHOU Shiqin, ZHOU Wen, AN Fangyu, WEI Benjun, LIU Yongqi
    2023, 28(4):  429-437.  doi:10.12092/j.issn.1009-2501.2023.04.010
    Asbtract ( 116 )   PDF (1983KB) ( 136 )  
    Related Articles | Metrics
    Acute lung injury (ALI) is a common clinical critical respiratory disease. At present, the mechanism of the disease has not been fully elucidated, there is a lack of specific drugs in clinical practice and the mortality rate is high, which is a difficult problem in the medical field. In recent years, traditional Chinese medicine has exerted its unique advantages and efficacy in the prevention and treatment of ALI, which has aroused the attention of domestic and foreign scholars. Based on the theory of "Wei Qi Ying Xue", this paper discusses the current research status of prevention and treatment of ALI by traditional Chinese medicine, and analyzes its pathogenesis, clinical manifestations and corresponding analysis with TCM syndrome. According to the angle of "Wei Qi Ying Xue", the progress of syndrome differentiation and treatment is highly consistent with immune response, inflammatory response, oxidative stress and apoptosis, in order to find new ideas and medication for the prevention and treatment of ALI with integrated traditional Chinese and Western medicine.
    Platelet-endothelial aggregation receptor 1 and its mediated signalling pathway Advances in the study of the role of platelets and endothelial cells
    LI Ruoning, GUO Zhanli, WANG Yuan, SUN Jianjun
    2023, 28(4):  438-444.  doi:10.12092/j.issn.1009-2501.2023.04.011
    Asbtract ( 189 )   PDF (1248KB) ( 244 )  
    Related Articles | Metrics
    Platelet-aggregation  receptor 1 (PEAR1) is a transmembrane receptor identified in 2005 and expressed mainly on platelets and endothelial cells. PEAR1 is a receptor protein that contacts platelets with each other and plays an important role in platelet activation and aggregation. Endothelial cells play an important role in maintaining vascular tone and vascular repair, and PEAR1 regulates the process of tumourigenesis and development by affecting their proliferation and associated neovascularisation. In recent years, PEAR1 has gradually been recognized as a potential target for anti-thrombotic drugs. This review focuses on elucidating the mechanisms of platelet endothelial aggregation receptor 1 and related signaling pathways in platelets and endothelial cells, and provides new ideas for the study of drug therapy for tumour-associated thrombosis.
    Research progress of lactate dehydrogenase A in digestive system tumors and related drugs
    WANG Siyu, LI Jiawei, LI Chenghao, LI Ling, GUO Qingyang, QIU Lu, ZHOU Shiqin, LIU Yongqi
    2023, 28(4):  445-454.  doi:10.12092/j.issn.1009-2501.2023.04.012
    Asbtract ( 179 )   PDF (1441KB) ( 242 )  
    Related Articles | Metrics
    Malignant tumors of digestive system are highly prevalent malignant tumors that seriously threaten human health around the world. At present, the curative efficacy and prognosis of traditional treatment methods cannot reach the expectation, so it is urgent to find new targets for cancer treatment and realize targeted therapy for tumors. Abnormal energy metabolism in tumor  cells is regarded as a hallmark of cancer, and malignant tumor cells absorb glucose through aerobic glycolysis pathway, and obtain a small amount of energy and produce lactate under the catalysis of a series of enzymes. Lactate dehydrogenase A (Lactate dehydrogenase A, LDHA), as a key enzyme in the aerobic glycolysis pathway of tumor cells, plays an important role in the metabolic changes of tumor cells. Studies have demonstrated that LDHA has high expression characteristics in a variety of tumor cells,and its high expression in clinic is often related to the poor prognosis and high metastasis rate of tumors, which is expected to be a new target for cancer therapy. This article reviews the role of LDHA in the development of digestive system tu- mors and the research progress of related drugs.
    Study on PLGA-based nanoparticles in gynecological diseases
    CHEN Yetao, HE Junyu, WU Mengyao, WAN Fangzhu, HE Haibo, TANG Hongbo
    2023, 28(4):  455-462.  doi:10.12092/j.issn.1009-2501.2023.04.013
    Asbtract ( 126 )   PDF (958KB) ( 110 )  
    Related Articles | Metrics
    Polylactic-co-glycolic acid (PLGA) has the characteristics of biocompatibility, biodegradability, modifiability, and slow release, which has attracted extensive attention in the treatment of gynecological diseases. This paper summarizes the relevant literature reports at home and abroad in recent years, expounds the research situation of PLGA nanoparticles as drug carriers in gynecological diseases such as ovarian cancer, breast cancer, cervical cancer and endometriosis, and looks forward to its great potential in clinical application in gynecological diseases, providing guidance for its prevention and treatment in gynecological diseases. 
    Controversies over the targets of controlling blood pressure in hyper- tensive patients with chronic kidney disease
    NING Sisi, ZHAO Yuhong, YAN Lei, TANG Minna, ZHANG Ningzhi, ZHANG Yongqiao, CUI Zhaoqiang
    2023, 28(4):  463-467.  doi:10.12092/j.issn.1009-2501.2023.04.014
    Asbtract ( 128 )   PDF (538KB) ( 93 )  
    Related Articles | Metrics
    The increasing incidence of chronic kid- ney disease (CKD) has become a major global public health problem. Hypertension and CKD can  cause and effect each other and often coexist. Controlling blood pressure is one of the core tasks in the treatment of CKD. Over the past 10 years, many large clinical studies have provided evidence-based medical evidence for the updating and revision of hypertension management guidelines, but there remains controversies in targets of blood pressure in hypertensive patients with CKD. Person- alized and evidence-based management is the key to achieve effective control of blood pressure and slow the progression of CKD. This review will summary the epidemiological status of hypertensive patients with CKD and the progress related to the targets of controlling blood pressure in CKD. 
    Research progress in population pharmacokinetics of rituximab
    LI Mengxue, HE Jie, YU Xiaxia, HU Linlin, SHAO Hua
    2023, 28(4):  468-474.  doi:10.12092/j.issn.1009-2501.2023.04.015
    Asbtract ( 315 )   PDF (638KB) ( 225 )  
    Related Articles | Metrics
    Rituximab, a chimeric human-mouse monoclonal antibody, has been used as a first-line treatment for CD20+ B-cell non-Hodgkin lymphoma in combination with chemotherapy. It is also used for autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus and immunemediated nephropathy. The clinical therapeutic effect of rituximab is significant. However, individual pharmacokinetics vary greatly, which bring some uncertainties to the efficacy and safety of clinical application, individualized treatment is needed to improve the rationality of its medication. Currently, studies on the optimization of rituximab administration regimen using population pharmacokinetics have been reported. Our paper reviewed the research progress in population pharmacokinetics of rituximab, aiming to provide reference to formulate an individualized dosing scheme of rituximab and realize precise administration for domestic patients.
    Research progress on the treatment of autism spectrum disorders based on gut microbiota intervention
    ZHANG Qiang, ZHENG Huajun, LI Quan
    2023, 28(4):  475-480.  doi:10.12092/j.issn.1009-2501.2023.04.016
    Asbtract ( 189 )   PDF (626KB) ( 181 )  
    Related Articles | Metrics
    Autism spectrum disorder is a set of neurodevelopmental disorders with unclear etiology and pathogenesis and no cure. Studies have found that the gut microbiota plays a vital role in the occurrence and development of autism spectrum disorder. By supplementing with probiotics, diet management or fecal microbial transplantation, the balance of gut microbiota can be adjusted to improve the behaviors and symptoms of patients with autism spectrum disorder. This article reviews from the perspective of regulating the bal- ance of gut microbiota to treat autism spectrum disorder, and aims to provide assistance for the re- search and treatment of autism spectrum disorder.